Bullish & Foolish
Full PHGE fundamentals All 466 on the Survival Watch

PHGEBIOMX INC.

Is Biomx struggling financially?

Yes, by its own account. Biomx told the SEC on 2 Jul 2026, in Form 8-K, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed Jul 2026

15/100

Critical

Sector
Biotech/Pharma
Market cap
$3.7M
Source filing
8-K 2 Jul 2026
Balance sheet
31 Mar 2026

Cash runway

  • 0months

    If the burn speeds up

    Empty by Mar 2026

  • 1month

    If it eases off

    Empty by May 2026

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$1.2M

÷

Cash burned over the last 12 months

$26.4M

What Biomx told the SEC

…and were not qualified or modified as to audit scope or accounting principles, except that each such report included an explanatory paragraph expressing substantial doubt as to the Company’s ability to continue as a going concern. The decision to dismiss PwC was recommended and approved by the Audit Committee and was ratified and approved by the Board. During the Company’s two most recent fiscal years ended…

BIOMX INC., Form 8-K, filed 2 Jul 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • Cash burn is narrowing It is spending 61% less cash per year than it was, so the runway above is lengthening rather than shortening.

Other Biotech/Pharma companies that filed the doubt